title: Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?
authors.forename: Udo
authors.initials: U
authors.lastname: Holtick
authors.forename: Nela
authors.initials: N
authors.lastname: Klein-Gonzalez
authors.forename: Michael S
authors.initials: MS
authors.lastname: von Bergwelt-Baildon
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007113:Immunity, Innate; D007167:Immunotherapy / Q000379:methods*; D023421:Models, Animal; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D051217:Toll-Like Receptor 9 / Q000819:agonists / Q000276:immunology
chemical_list: D000970:Antineoplastic Agents; D051217:Toll-Like Receptor 9